INTRAVENOUS THROMBOLYSIS AND CLOT RETRIEVAL FOLLOWING REVERSAL OF DABIGATRAN WITH IDARUCIZUMAB

被引：1
|
作者：
Tse, Dominic M. Y. [1 ]
Young, Laura [2 ]
Ranta, Anna M. [3 ]
Barber, P. A. [1 ]
机构：
[1] Auckland Dist Hlth Board, Dept Neurol, Auckland, New Zealand
[2] Auckland Dist Hlth Board, Dept Haematol, Auckland, New Zealand
[3] Univ Otago, Auckland, New Zealand
来源：
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY | 2017年 / 88卷 / 05期
关键词：
D O I：
10.1136/jnnp-2017-316074.7
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
7
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Incomplete dabigatran reversal with idarucizumab
    Steele, Aaron P.
    Lee, Jin A.
    Dager, William E.
    CLINICAL TOXICOLOGY, 2018, 56 (03) : 216 - 218
  • [32] Dabigatran Reversal with Idarucizumab Reply
    Pollack, Charles V., Jr.
    Reilly, Paul A.
    Weitz, Jeffrey I.
    NEW ENGLAND JOURNAL OF MEDICINE, 2017, 377 (17): : 1691 - 1692
  • [33] Successful intravenous thrombolysis in acute ischemic stroke after reversal of dabigatran etexilate with idarucizumab at the end of therapeutic time window
    Vukorepa, Gorana
    Devedija, Sabina
    Crnjakovic, Miljenko
    Karakas, Mirna
    Cuk, Zeljka
    TURKISH JOURNAL OF EMERGENCY MEDICINE, 2020, 20 (02): : 90 - 92
  • [34] Neuropsychological outcomes following endovascular clot retrieval and intravenous thrombolysis in ischemic stroke
    Humphrey, Sam
    Pike, Kerryn E.
    Long, Brian
    Ma, Henry
    Bourke, Robert
    Wright, Bradley J.
    Wong, Dana
    JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY, 2024,
  • [35] Evidence Supporting Idarucizumab for the Reversal of Dabigatran
    Pollack, Charles V., Jr.
    AMERICAN JOURNAL OF MEDICINE, 2016, 129 (11): : S73 - S79
  • [36] Reversal of dabigatran by idarucizumab: when and how?
    Vanassche, Thomas
    Greinacher, Andreas
    Verhamme, Peter
    EXPERT REVIEW OF HEMATOLOGY, 2016, 9 (06) : 519 - 528
  • [37] Adverse clinical outcomes after dabigatran reversal with idarucizumab to facilitate acute stroke thrombolysis
    Ng, Felix C.
    Bice, James
    Rodda, Anne
    Lee-Archer, Matthew
    Crompton, Douglas E.
    JOURNAL OF NEUROLOGY, 2017, 264 (03) : 591 - 594
  • [38] Idarucizumab: A Review as a Reversal Agent for Dabigatran
    Yahiya Y. Syed
    American Journal of Cardiovascular Drugs, 2016, 16 : 297 - 304
  • [39] Evidence supporting idarucizumab for the reversal of dabigatran
    Pollack, Charles V., Jr.
    AMERICAN JOURNAL OF EMERGENCY MEDICINE, 2016, 34 (11): : 33 - 38
  • [40] Adverse clinical outcomes after dabigatran reversal with idarucizumab to facilitate acute stroke thrombolysis
    Felix C. Ng
    James Bice
    Anne Rodda
    Matthew Lee-Archer
    Douglas E. Crompton
    Journal of Neurology, 2017, 264 : 591 - 594
12345